• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响社区药剂师对慢性肾脏病患者进行干预的信念:基于理论的定性研究。

Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.

机构信息

Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.

Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Sanofi Aventis Endowment Chair in Ambulatory Pharmaceutical Care, Université de Montréal, Centre Intégré de Santé et de Services Sociaux de Laval, Quebec, Canada.

出版信息

Res Social Adm Pharm. 2019 Feb;15(2):145-153. doi: 10.1016/j.sapharm.2018.04.004. Epub 2018 Apr 6.

DOI:10.1016/j.sapharm.2018.04.004
PMID:29709530
Abstract

BACKGROUND

Drug-related problems (DRPs) are highly prevalent in chronic kidney disease (CKD) patients. Community pharmacists are ideally positioned to manage these DRPs. However, little is known about the factors influencing their interventions with CKD patients.

OBJECTIVES

Using the theory of planned behavior (TPB), this qualitative study sought to: (1) explore the behavioral beliefs (perceived advantages and disadvantages), normative beliefs (perceived expectations of significant others) and control beliefs (perceived barriers and facilitators) influencing community pharmacists' interventions related to identifying and managing DRPs in CKD; and (2) compare these beliefs among three DRPs prevalent in CKD patients.

METHODS

Community pharmacists in Quebec, Canada participated in face-to-face individual semi-structured interviews. The topic guide was based on the TPB. Three vignettes were presented to stimulate community pharmacists' thoughts about their interventions regarding: (1) the use of an inappropriate over-the-counter laxative; (2) prescriptions of anti-inflammatory medications; and (3) non-adherence to antihypertensive medication. Integral transcripts of audio recordings were analyzed using thematic analysis. The findings on each of the three DRPs were systematically compared.

RESULTS

Fifteen community pharmacists participated in the study. All expressed a positive attitude toward DRP management, mentioning advantages such as gaining the patient's loyalty as a client and avoiding CKD complications. Participants mentioned that patients and physicians generally approve their interventions, but the dynamics of these relationships may vary depending on the DRP. Common barriers in the management of the three DRPs were the pharmacists' limited time and heavy workloads. The pharmacists felt that the main disadvantage is that these interventions interrupt the workflow in the pharmacy.

CONCLUSION

Community pharmacists hold positive views of their interventions in CKD. However, enhancing community pharmacists' involvement in CKD care may require measures to facilitate pharmacists' proactivity, inter-professional collaboration and a work organization adapted to clinical activities.

摘要

背景

药物相关问题(DRPs)在慢性肾脏病(CKD)患者中非常普遍。社区药剂师是管理这些 DRPs 的理想人选。然而,对于影响他们对 CKD 患者干预的因素知之甚少。

目的

本研究使用计划行为理论(TPB),旨在:(1)探讨影响社区药剂师干预 CKD 患者识别和管理 DRPs 的行为信念(感知优势和劣势)、规范信念(感知重要他人的期望)和控制信念(感知障碍和促进因素);(2)比较三种在 CKD 患者中常见的 DRPs 之间的这些信念。

方法

加拿大魁北克省的社区药剂师参加了面对面的个人半结构化访谈。主题指南基于 TPB。呈现了三个案例来激发社区药剂师对以下方面的干预措施的思考:(1)使用不适当的非处方轻泻剂;(2)开具抗炎药物;(3)不遵守抗高血压药物治疗。使用主题分析对音频记录的完整转录本进行分析。对三种 DRP 中的每一种的发现进行了系统比较。

结果

15 名社区药剂师参加了研究。所有人都对 DRP 管理持积极态度,提到了一些优势,例如赢得患者作为客户的忠诚度并避免 CKD 并发症。参与者提到,患者和医生通常都认可他们的干预措施,但这些关系的动态可能因 DRP 而异。在管理三种 DRP 时的共同障碍是药剂师有限的时间和繁重的工作量。药剂师认为,主要的缺点是这些干预措施会中断药店的工作流程。

结论

社区药剂师对其在 CKD 中的干预措施持有积极的看法。然而,要增强社区药剂师对 CKD 护理的参与,可能需要采取措施促进药剂师的积极性、跨专业合作以及适应临床活动的工作组织。

相似文献

1
Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.影响社区药剂师对慢性肾脏病患者进行干预的信念:基于理论的定性研究。
Res Social Adm Pharm. 2019 Feb;15(2):145-153. doi: 10.1016/j.sapharm.2018.04.004. Epub 2018 Apr 6.
2
Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.社区药师培训与沟通网络对慢性肾脏病患者药物相关问题的影响:一项多中心、整群随机对照试验
Am J Kidney Dis. 2017 Sep;70(3):386-396. doi: 10.1053/j.ajkd.2017.05.008. Epub 2017 Jun 26.
3
Pharmaceutical care research and education project: pharmacists' interventions.药学服务研究与教育项目:药剂师的干预措施
J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):401-10. doi: 10.1016/s1086-5802(16)31254-2.
4
Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.从社区药剂师的角度看近期出院患者药物重整流程的障碍与促进因素
Res Social Adm Pharm. 2015 Jul-Aug;11(4):517-30. doi: 10.1016/j.sapharm.2014.10.008. Epub 2014 Oct 25.
5
Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.基于社区药店的哮喘干预措施的可感知可行性:一项定性随访研究。
J Clin Pharm Ther. 2011 Jun;36(3):348-55. doi: 10.1111/j.1365-2710.2010.01187.x. Epub 2010 Oct 19.
6
Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.澳大利亚社区药剂师实施慢性肾脏病风险评估服务的经验。
Prev Chronic Dis. 2018 Jun 14;15:E81. doi: 10.5888/pcd15.170485.
7
Community pharmacists' naloxone counseling: A theory-informed qualitative study.社区药剂师的纳洛酮咨询:基于理论的定性研究。
J Am Pharm Assoc (2003). 2023 Nov-Dec;63(6):1743-1752.e2. doi: 10.1016/j.japh.2023.08.018. Epub 2023 Aug 24.
8
Practical evaluation of the drug-related problem management process in Swiss community pharmacies.瑞士社区药房药物相关问题管理流程的实践评估
Pharm World Sci. 2008 Dec;30(6):777-86. doi: 10.1007/s11096-008-9217-4. Epub 2008 Apr 6.
9
Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.药物相关问题的特征及药师在泰国卒中单元的干预措施。
Int J Clin Pharm. 2019 Aug;41(4):880-887. doi: 10.1007/s11096-019-00832-4. Epub 2019 May 3.
10
Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.按严重程度分层的慢性肾脏病患者药物相关问题的流行情况和处理:社区药房一项集群随机对照试验的亚组分析。
J Manag Care Spec Pharm. 2018 Feb;24(2):173-181. doi: 10.18553/jmcp.2018.24.2.173.

引用本文的文献

1
Community pharmacists' perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains framework.社区药剂师对晚期慢性肾病患者肾功能评估及药物剂量调整的看法:一项运用理论域框架的定性研究
Can Pharm J (Ott). 2023 Jul 7;156(5):272-281. doi: 10.1177/17151635231176530. eCollection 2023 Sep-Oct.
2
Applying the Theory of Planned Behavior to predict community pharmacists' intention to provide diabetes care.运用计划行为理论预测社区药剂师提供糖尿病护理的意愿。
BMC Health Serv Res. 2022 Dec 5;22(1):1479. doi: 10.1186/s12913-022-08788-4.
3
Importance of pharmacist-patient relationship in people living with HIV and concomitant opioid use disorder.
药剂师与患者关系在艾滋病毒感染者及同时患有阿片类物质使用障碍者中的重要性。
Explor Res Clin Soc Pharm. 2021 Jul 31;3:100052. doi: 10.1016/j.rcsop.2021.100052. eCollection 2021 Sep.
4
Qualitative Investigation of Community Pharmacy Immunization Enhancement Program Implementation.社区药房免疫增强计划实施的定性调查
J Pharm Technol. 2019 Oct;35(5):208-218. doi: 10.1177/8755122519852584. Epub 2019 Jun 14.
5
Implementation of a Real-Time Medication Intake Monitoring Technology Intervention in Community Pharmacy Settings: A Mixed-Method Pilot Study.在社区药房环境中实施实时药物摄入监测技术干预:一项混合方法试点研究。
Pharmacy (Basel). 2021 May 25;9(2):105. doi: 10.3390/pharmacy9020105.
6
Patients' and healthcare professionals' beliefs, perceptions and needs towards chronic kidney disease self-management in China: a qualitative study.患者和医疗保健专业人员对中国慢性肾脏病自我管理的信念、看法和需求:一项定性研究。
BMJ Open. 2021 Mar 4;11(3):e044059. doi: 10.1136/bmjopen-2020-044059.
7
Clinical Pharmacy Activities Documented (ClinPhADoc): Development, Reliability and Acceptability of a Documentation Tool for Community Pharmacists.临床药学活动记录(ClinPhADoc):一种社区药剂师记录工具的开发、可靠性和可接受性
Pharmacy (Basel). 2019 Dec 2;7(4):162. doi: 10.3390/pharmacy7040162.